Cystic fibrosis 2018 Global Market Challenge, Driver, Trends & Forecast to 2023

Cystic fibrosis Market Import | Export Outlook and Global Foresight 2023

PUNE, INDIA, June 29, 2018 / -- Cystic fibrosis is a chronic, genetic disease which affects the productivity of the body leading to severe disability and early death. Symptoms of cystic fibrosis include frequent lung infections, diarrhea, and poor growth of the body. The global cystic fibrosis market is expected to reach USD 8852.2 million by 2022 at a CAGR of 13.5% during the forecast period.


The global cystic fibrosis market is segmented on the basis of treatment method which includes Medication, Devices and Other Treatments. Medicines capture the maximum share in the cystic fibrosis market. Medication segment accounted market share in all the regions across the global
On the basis of region, the market is segmented into four major regions namely North America, Europe, Asia-Pacific and Middle East & Africa. North America accounted for the largest market share in the global cystic fibrosis market while Asia pacific is the fastest growing region in this market.

Key Players:
The leading market players in the global cystic fibrosis market include AbbVie, Allergan Plc., Chiesi Farmaceutici S.p.A., F. Hoffmann-La Roche AG, Gilead Sciences, Novartis AG, Pharmaxis Ltd., PTC Therapeutics, and Vertex Pharmaceuticals Incorporated.

Study objectives of cystic fibrosis market:
Ø To provide insights about factors influencing and affecting the market growth
Ø To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets
Ø To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Target Audience:
• Pharmaceutical companies
• Hospitals & Clinics
• Potential investors
• Key executive (CEO and COO) and strategy growth manager

Key Findings:
• The global market for cystic fibrosis is expected to reach USD 8852.2 million by 2022 from USD 3652.2 million in 2016.
• Americas commands largest market share in 2016, it is expected to reach USD 3882.5 million by 2022.
• Asia-Pacific registers fastest growing CAGR of 13.5% during the forecast period from 2017-2022.

Table of Content: Key Points
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Cystic Fibrosis Market, By Treatment Method
6 Cystic Fibrosis Market, By Regions
7 Company Share Analysis


Get in touch:

Norah Trent
+1 646 845 9349 / +44 208 133 9349
email us here

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.